Skip to main content

and
  1. No Access

    Article

    Combined Erlotinib and Cetuximab overcome the acquired resistance to epidermal growth factor receptors tyrosine kinase inhibitor in non-small-cell lung cancer

    Non-small-cell lung cancer (NSCLC) cells with somatic mutations in epidermal growth factor receptors (EGFR) are initially susceptible to tyrosine kinase inhibitor (TKI); however, eventually resistance to TKI i...

    Meng Wang, **g Zhao, Lian-Min Zhang, Hui Li in Journal of Cancer Research and Clinical On… (2012)